Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1919 1
1945 1
1949 2
1951 2
1952 1
1953 1
1954 2
1955 1
1956 1
1957 1
1958 4
1959 4
1960 8
1961 8
1962 14
1963 12
1964 17
1965 17
1966 11
1967 10
1968 14
1969 18
1970 23
1971 30
1972 23
1973 29
1974 24
1975 29
1976 36
1977 32
1978 32
1979 26
1980 29
1981 28
1982 28
1983 29
1984 43
1985 26
1986 42
1987 38
1988 31
1989 25
1990 29
1991 22
1992 22
1993 27
1994 22
1995 19
1996 14
1997 7
1998 13
1999 27
2000 17
2001 19
2002 14
2003 24
2004 22
2005 20
2006 17
2007 14
2008 17
2009 16
2010 11
2011 21
2012 12
2013 12
2014 14
2015 22
2016 35
2017 31
2018 31
2019 24
2020 27
2021 30
2022 23
2023 25
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

1,418 results

Results by year

Filters applied: . Clear all
Page 1
Therapy with oncolytic viruses: progress and challenges.
Shalhout SZ, Miller DM, Emerick KS, Kaufman HL. Shalhout SZ, et al. Among authors: kaufman hl. Nat Rev Clin Oncol. 2023 Mar;20(3):160-177. doi: 10.1038/s41571-022-00719-w. Epub 2023 Jan 11. Nat Rev Clin Oncol. 2023. PMID: 36631681 Review.
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death.
Galluzzi L, Vitale I, Warren S, Adjemian S, Agostinis P, Martinez AB, Chan TA, Coukos G, Demaria S, Deutsch E, Draganov D, Edelson RL, Formenti SC, Fucikova J, Gabriele L, Gaipl US, Gameiro SR, Garg AD, Golden E, Han J, Harrington KJ, Hemminki A, Hodge JW, Hossain DMS, Illidge T, Karin M, Kaufman HL, Kepp O, Kroemer G, Lasarte JJ, Loi S, Lotze MT, Manic G, Merghoub T, Melcher AA, Mossman KL, Prosper F, Rekdal Ø, Rescigno M, Riganti C, Sistigu A, Smyth MJ, Spisek R, Stagg J, Strauss BE, Tang D, Tatsuno K, van Gool SW, Vandenabeele P, Yamazaki T, Zamarin D, Zitvogel L, Cesano A, Marincola FM. Galluzzi L, et al. Among authors: kaufman hl. J Immunother Cancer. 2020 Mar;8(1):e000337. doi: 10.1136/jitc-2019-000337. J Immunother Cancer. 2020. PMID: 32209603 Free PMC article. Review.
Immunotherapy for Non-melanoma Skin Cancer.
Shalhout SZ, Emerick KS, Kaufman HL, Miller DM. Shalhout SZ, et al. Among authors: kaufman hl. Curr Oncol Rep. 2021 Aug 27;23(11):125. doi: 10.1007/s11912-021-01120-z. Curr Oncol Rep. 2021. PMID: 34448958 Free PMC article. Review.
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma.
Gross ND, Miller DM, Khushalani NI, Divi V, Ruiz ES, Lipson EJ, Meier F, Su YB, Swiecicki PL, Atlas J, Geiger JL, Hauschild A, Choe JH, Hughes BGM, Schadendorf D, Patel VA, Homsi J, Taube JM, Lim AM, Ferrarotto R, Kaufman HL, Seebach F, Lowy I, Yoo SY, Mathias M, Fenech K, Han H, Fury MG, Rischin D. Gross ND, et al. Among authors: kaufman hl. N Engl J Med. 2022 Oct 27;387(17):1557-1568. doi: 10.1056/NEJMoa2209813. Epub 2022 Sep 12. N Engl J Med. 2022. PMID: 36094839 Free PMC article. Clinical Trial.
Clinical landscape of oncolytic virus research in 2020.
Macedo N, Miller DM, Haq R, Kaufman HL. Macedo N, et al. Among authors: kaufman hl. J Immunother Cancer. 2020 Oct;8(2):e001486. doi: 10.1136/jitc-2020-001486. J Immunother Cancer. 2020. PMID: 33046622 Free PMC article. Review.
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma.
Andtbacka RH, Kaufman HL, Collichio F, Amatruda T, Senzer N, Chesney J, Delman KA, Spitler LE, Puzanov I, Agarwala SS, Milhem M, Cranmer L, Curti B, Lewis K, Ross M, Guthrie T, Linette GP, Daniels GA, Harrington K, Middleton MR, Miller WH Jr, Zager JS, Ye Y, Yao B, Li A, Doleman S, VanderWalde A, Gansert J, Coffin RS. Andtbacka RH, et al. Among authors: kaufman hl. J Clin Oncol. 2015 Sep 1;33(25):2780-8. doi: 10.1200/JCO.2014.58.3377. Epub 2015 May 26. J Clin Oncol. 2015. PMID: 26014293 Clinical Trial.
Oncolytic Immunotherapy.
Hennessy ML, Bommareddy PK, Boland G, Kaufman HL. Hennessy ML, et al. Among authors: kaufman hl. Surg Oncol Clin N Am. 2019 Jul;28(3):419-430. doi: 10.1016/j.soc.2019.02.007. Epub 2019 Apr 5. Surg Oncol Clin N Am. 2019. PMID: 31079797 Review.
Reply.
McClure LF, Niles JK, Kaufman HW. McClure LF, et al. Among authors: kaufman hw. J Pediatr. 2017 Feb;181:330-331. doi: 10.1016/j.jpeds.2016.09.049. Epub 2016 Nov 3. J Pediatr. 2017. PMID: 27817880 No abstract available.
Conclusion.
Kaufman H. Kaufman H. J Wound Care. 2020 May 1;29(Sup5b):S31. doi: 10.12968/jowc.2020.29.Sup5b.S31. J Wound Care. 2020. PMID: 32427024 No abstract available.
1,418 results